Location History:
- Machida, JP (2005 - 2006)
- Midori-ku, JP (2010)
- Tokyo, JP (2007 - 2016)
Company Filing History:
2 out of 567 
2 out of 730 
1 out of 5,309 
Years Active: 2005-2016
Title: Masaaki Wachi: Innovator in Antimicrobial Research
Introduction
Masaaki Wachi is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of antimicrobial research, particularly in the development of new therapeutic agents for malaria and bacterial infections. With a total of 5 patents, Wachi's work is recognized for its potential impact on public health.
Latest Patents
Wachi's latest patents include an innovative antimalarial drug that comprises alaremycin or its derivatives as an active ingredient. This preventive and therapeutic agent for malaria utilizes 5-acetamido-4-oxo-5-hexenoic acid (Alaremycin) to combat the disease effectively. The formulation allows for various substitutions in its chemical structure, enhancing its therapeutic potential. Another notable patent focuses on antibiotics targeting MreB, a protein essential for bacterial chromosome segregation. This discovery opens new avenues for antibiotic development, particularly through the use of isothiourea compounds that can effectively target microbial infections.
Career Highlights
Masaaki Wachi has worked with esteemed institutions such as the Tokyo Institute of Technology and Kyowa Hakko Kogyo Co., Ltd. His research has been pivotal in advancing the understanding of antibiotic mechanisms and developing new therapeutic strategies.
Collaborations
Wachi has collaborated with notable researchers, including Kazuo Nagai and Zemer Gitai. These partnerships have fostered innovative approaches to tackling microbial resistance and improving treatment options.
Conclusion
Masaaki Wachi's contributions to antimicrobial research highlight his role as a leading inventor in the field. His innovative patents and collaborations continue to pave the way for advancements in medical treatments.